These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 36291102)

  • 21. Extracellular 20S proteasome secreted via microvesicles can degrade poorly folded proteins and inhibit Galectin-3 agglutination activity.
    Bonhoure A; Henry L; Bich C; Blanc L; Bergeret B; Bousquet MP; Coux O; Stoebner PE; Vidal M
    Traffic; 2022 May; 23(5):287-304. PubMed ID: 35466519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Contribution of the 20S Proteasome to Proteostasis.
    Kumar Deshmukh F; Yaffe D; Olshina MA; Ben-Nissan G; Sharon M
    Biomolecules; 2019 May; 9(5):. PubMed ID: 31100951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyubiquitin substrates allosterically activate their own degradation by the 26S proteasome.
    Bech-Otschir D; Helfrich A; Enenkel C; Consiglieri G; Seeger M; Holzhütter HG; Dahlmann B; Kloetzel PM
    Nat Struct Mol Biol; 2009 Feb; 16(2):219-25. PubMed ID: 19169257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ubiquitin-independent protein degradation in proteasomes].
    Buneeva OA; Medvedev AE
    Biomed Khim; 2018 Mar; 64(2):134-148. PubMed ID: 29723144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ηigh-resolution structure of mammalian PI31-20S proteasome complex reveals mechanism of proteasome inhibition.
    Hsu HC; Wang J; Kjellgren A; Li H; DeMartino GN
    J Biol Chem; 2023 Jul; 299(7):104862. PubMed ID: 37236357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small Molecule Enhancement of 20S Proteasome Activity Targets Intrinsically Disordered Proteins.
    Jones CL; Njomen E; Sjögren B; Dexheimer TS; Tepe JJ
    ACS Chem Biol; 2017 Sep; 12(9):2240-2247. PubMed ID: 28719185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoaffinity purification of the functional 20S proteasome from human cells via transient overexpression of specific proteasome subunits.
    Livinskaya VA; Barlev NA; Nikiforov AA
    Protein Expr Purif; 2014 May; 97():37-43. PubMed ID: 24583181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proteasomal degradation of the intrinsically disordered protein tau at single-residue resolution.
    Ukmar-Godec T; Fang P; Ibáñez de Opakua A; Henneberg F; Godec A; Pan KT; Cima-Omori MS; Chari A; Mandelkow E; Urlaub H; Zweckstetter M
    Sci Adv; 2020 Jul; 6(30):eaba3916. PubMed ID: 32832664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein Interaction between Ameloblastin and Proteasome Subunit α Type 3 Can Facilitate Redistribution of Ameloblastin Domains within Forming Enamel.
    Geng S; White SN; Paine ML; Snead ML
    J Biol Chem; 2015 Aug; 290(34):20661-20673. PubMed ID: 26070558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, Synthesis, and Biological Evaluation of Potent 20S Proteasome Activators for the Potential Treatment of α-Synucleinopathies.
    Staerz SD; Jones CL; Tepe JJ
    J Med Chem; 2022 May; 65(9):6631-6642. PubMed ID: 35476454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a Cell-Based AlphaLISA Assay for High-Throughput Screening for Small Molecule Proteasome Modulators.
    Staerz SD; Lisabeth EM; Njomen E; Dexheimer TS; Neubig RR; Tepe JJ
    ACS Omega; 2023 May; 8(17):15650-15659. PubMed ID: 37151549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential Interactions of the Proteasome Inhibitor PI31 with Constitutive and Immuno-20S Proteasomes.
    Wang J; Kjellgren A; DeMartino GN
    Biochemistry; 2024 Apr; 63(8):1000-1015. PubMed ID: 38577872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulating the 20S proteasome ubiquitin-independent degradation pathway.
    Ben-Nissan G; Sharon M
    Biomolecules; 2014 Sep; 4(3):862-84. PubMed ID: 25250704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative analysis of proteins associated with 26S and 20S proteasomes isolated from rabbit brain and liver].
    Buneeva OA; Kopylov AT; Zgoda VG; Gnedenko OV; Kaloshina SA; Medvedeva MV; Ivanov AS; Medvedev AE
    Biomed Khim; 2022 Jan; 68(1):18-31. PubMed ID: 35221293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aim for the core: suitability of the ubiquitin-independent 20S proteasome as a drug target in neurodegeneration.
    Opoku-Nsiah KA; Gestwicki JE
    Transl Res; 2018 Aug; 198():48-57. PubMed ID: 30244692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design Principles Involving Protein Disorder Facilitate Specific Substrate Selection and Degradation by the Ubiquitin-Proteasome System.
    Guharoy M; Bhowmick P; Tompa P
    J Biol Chem; 2016 Mar; 291(13):6723-31. PubMed ID: 26851277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variably modulated gating of the 26S proteasome by ATP and polyubiquitin.
    Li X; Demartino GN
    Biochem J; 2009 Jul; 421(3):397-404. PubMed ID: 19435460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Backbone ¹H, ¹³C and ¹⁵N assignments of yeast Ump1, an intrinsically disordered protein that functions as a proteasome assembly chaperone.
    Uekusa Y; Okawa K; Yagi-Utsumi M; Serve O; Nakagawa Y; Mizushima T; Yagi H; Saeki Y; Tanaka K; Kato K
    Biomol NMR Assign; 2014 Oct; 8(2):383-6. PubMed ID: 24065419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immuno-oncological role of 20S proteasome alpha-subunit 3 in aggravating the progression of esophageal squamous cell carcinoma.
    Liu J; Shao J; Zhang C; Qin G; Liu J; Li M; Wu P; Zhao X; Zhang Y
    Eur J Immunol; 2022 Feb; 52(2):338-351. PubMed ID: 34755333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 26S Proteasome Switches between ATP-Dependent and -Independent Mechanisms in Response to Substrate Ubiquitination.
    Manfredonia AJ; Kraut DA
    Biomolecules; 2022 May; 12(6):. PubMed ID: 35740875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.